{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,28]],"date-time":"2026-09-28T13:10:49Z","timestamp":1790601049629,"version":"4.1.0"},"reference-count":39,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2024,3,1]],"date-time":"2024-03-01T00:00:00Z","timestamp":1709251200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2024,3,1]],"date-time":"2024-03-01T00:00:00Z","timestamp":1709251200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"}],"funder":[{"DOI":"10.13039\/501100003130","name":"FWO","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100003130","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100004040","name":"KU Leuven","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100004040","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["ejpn-journal.com","clinicalkey.fr","clinicalkey.jp","clinicalkey.es","clinicalkey.com.au","clinicalkey.com","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["European Journal of Paediatric Neurology"],"published-print":{"date-parts":[[2024,3]]},"DOI":"10.1016\/j.ejpn.2024.02.017","type":"journal-article","created":{"date-parts":[[2024,3,1]],"date-time":"2024-03-01T10:22:39Z","timestamp":1709288559000},"page":"131-140","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":4,"special_numbering":"C","title":["Botulinum neurotoxin type A responders among children with spastic cerebral palsy: Pattern-specific effects"],"prefix":"10.1016","volume":"49","author":[{"ORCID":"https:\/\/orcid.org\/0000-0003-0903-2490","authenticated-orcid":false,"given":"E.","family":"Papageorgiou","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-0380-9174","authenticated-orcid":false,"given":"N.","family":"Peeters","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"L.","family":"Staut","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"G.","family":"Molenaers","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"E.","family":"Ortibus","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"A.","family":"Van Campenhout","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"K.","family":"Desloovere","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.ejpn.2024.02.017_bib1","article-title":"Cerebral palsy","volume":"2","author":"Graham","year":"2016","journal-title":"Nat. Rev. Dis. Prim."},{"issue":"8","key":"10.1016\/j.ejpn.2024.02.017_bib2","doi-asserted-by":"crossref","first-page":"1","DOI":"10.3390\/toxins9080253","article-title":"Efficacy of repeated botulinum toxin type a injections for spastic equinus in children with cerebral palsy\u2014a secondary analysis of the randomized clinical trial","volume":"9","author":"Hong","year":"2017","journal-title":"Toxins"},{"issue":"8","key":"10.1016\/j.ejpn.2024.02.017_bib3","doi-asserted-by":"crossref","first-page":"e4","DOI":"10.2106\/JBJS.RVW.18.00153","article-title":"Sarcopenia, cerebral palsy, and botulinum toxin type A","volume":"7","author":"Multani","year":"2019","journal-title":"JBJS Rev"},{"issue":"2","key":"10.1016\/j.ejpn.2024.02.017_bib4","first-page":"1","article-title":"State of the evidence traffic lights 2019: systematic review of interventions for preventing and treating children with cerebral palsy","volume":"20","author":"Novak","year":"2020","journal-title":"Curr Neurol Neurosci Rep [Internet"},{"key":"10.1016\/j.ejpn.2024.02.017_bib5","article-title":"Botulinum toxin type A in the treatment of lower limb spasticity in cerebral palsy","volume":"10","author":"Blumetti","year":"2019","journal-title":"Cochrane Database Syst. Rev."},{"issue":"3","key":"10.1016\/j.ejpn.2024.02.017_bib6","article-title":"Literature review and comparison of two statistical methods to evaluate the effect of botulinum toxin treatment on gait in children with cerebral palsy","volume":"11","author":"Nieuwenhuys","year":"2016","journal-title":"PLoS One [Internet"},{"issue":"1","key":"10.1016\/j.ejpn.2024.02.017_bib7","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1055\/s-0039-1694988","article-title":"Botulinum toxin in children with cerebral palsy: an update","volume":"51","author":"Hareb","year":"2020","journal-title":"Neuropediatrics"},{"issue":"1","key":"10.1016\/j.ejpn.2024.02.017_bib8","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1186\/s12887-019-1906-8","article-title":"A\u00a0prospective study investigating gross motor function of children with cerebral palsy and GMFCS level II after long-term Botulinum toxin type A use","volume":"20","author":"Valentine","year":"2020","journal-title":"BMC Pediatr."},{"issue":"4","key":"10.1016\/j.ejpn.2024.02.017_bib9","first-page":"51","article-title":"Botulinum toxin type A treatment of cerebral palsy: an integrated approach","volume":"6","author":"Molenaers","year":"1999","journal-title":"Eur. J. Neurol."},{"issue":"5","key":"10.1016\/j.ejpn.2024.02.017_bib10","first-page":"757","article-title":"Effect of physiotherapeutic intervention on the gait after the application of botulinum toxin in children with cerebral palsy: systematic review","volume":"54","author":"Fonseca","year":"2018","journal-title":"Eur J Phys Rehabil Med [Internet"},{"issue":"2, SI","key":"10.1016\/j.ejpn.2024.02.017_bib11","doi-asserted-by":"crossref","first-page":"9","DOI":"10.1111\/j.1468-1331.2010.03126.x","article-title":"Botulinum toxin assessment, intervention and after-care for lower limb spasticity in children with cerebral palsy: international consensus statement","volume":"17","author":"Love","year":"2010","journal-title":"Eur. J. Neurol."},{"issue":"1","key":"10.1016\/j.ejpn.2024.02.017_bib12","doi-asserted-by":"crossref","first-page":"45","DOI":"10.1016\/j.ejpn.2009.09.005","article-title":"The updated European Consensus 2009 on the use of Botulinum toxin for children with cerebral palsy","volume":"14","author":"Heinen","year":"2010","journal-title":"Eur. J. Paediatr. Neurol."},{"key":"10.1016\/j.ejpn.2024.02.017_bib13","doi-asserted-by":"crossref","first-page":"709","DOI":"10.1111\/j.1469-8749.2005.tb01062.x","article-title":"Botulinum toxin and cerebral palsy: time for reflection?","volume":"47","author":"Gough","year":"2006","journal-title":"Dev. Med. Child Neurol."},{"key":"10.1016\/j.ejpn.2024.02.017_bib14","article-title":"Botulinum toxin in the management of children with cerebral palsy","author":"Multani","year":"2019","journal-title":"Pediatr Drugs [Internet]"},{"key":"10.1016\/j.ejpn.2024.02.017_bib15","doi-asserted-by":"crossref","first-page":"783","DOI":"10.1111\/dmcn.14056","article-title":"Medial gastrocnemius volume and echo-intensity after botulinum neurotoxin A interventions in children with spastic cerebral palsy","volume":"61","author":"Schless","year":"2019","journal-title":"Dev. Med. Child Neurol."},{"issue":"3","key":"10.1016\/j.ejpn.2024.02.017_bib16","doi-asserted-by":"crossref","first-page":"1052","DOI":"10.1016\/j.ridd.2012.11.016","article-title":"Botulinum toxin type A injections in the psoas muscle of children with cerebral palsy : muscle atrophy after motor end plate-targeted injections","volume":"34","author":"Van Campenhout","year":"2013","journal-title":"Res Dev Disabil [Internet]"},{"issue":"4","key":"10.1016\/j.ejpn.2024.02.017_bib17","doi-asserted-by":"crossref","first-page":"392","DOI":"10.1136\/archdischild-2013-305805","article-title":"Question 1: is there any long-term benefit from injecting botulinum toxin-A into children with cerebral palsy?","volume":"99","author":"Bradley","year":"2014","journal-title":"Arch. Dis. Child."},{"issue":"1","key":"10.1016\/j.ejpn.2024.02.017_bib18","first-page":"1","article-title":"Short-term causal effects of common treatments in ambulatory children and young adults with cerebral palsy: three machine learning estimates","volume":"12","author":"Schwartz","year":"2022","journal-title":"Sci Rep [Internet]"},{"key":"10.1016\/j.ejpn.2024.02.017_bib19","volume":"vols. 1\u201321","author":"Peeters","year":"2022"},{"issue":"April","key":"10.1016\/j.ejpn.2024.02.017_bib20","article-title":"Single-event multilevel surgery, but not botulinum toxin injections normalize joint loading in cerebral palsy patients","volume":"76","author":"Van Rossom","year":"2020","journal-title":"Clin Biomech [Internet]"},{"issue":"2","key":"10.1016\/j.ejpn.2024.02.017_bib21","doi-asserted-by":"crossref","first-page":"S172","DOI":"10.1097\/BPO.0b013e31825eb2a6","article-title":"Management of children with ambulatory cerebral palsy: an evidence-based review","volume":"32","author":"Narayanan","year":"2012","journal-title":"J\u00a0Pediatr Orthop [Internet]"},{"issue":"1","key":"10.1016\/j.ejpn.2024.02.017_bib22","doi-asserted-by":"crossref","first-page":"206","DOI":"10.1093\/ptj\/67.2.206","article-title":"Interrater reliability of a modified ashworth scale of muscle spasticity","volume":"67","author":"Bohannon","year":"1987","journal-title":"Phys. Ther."},{"key":"10.1016\/j.ejpn.2024.02.017_bib23","series-title":"Daniels and Worthingham's Muscle Testing: Techniques of Manual Examination","first-page":"496","author":"Hislop","year":"2007"},{"key":"10.1016\/j.ejpn.2024.02.017_bib24","series-title":"The Treatment of Gait Problems in Cerebral Palsy Clinics in Developmental Medicine No 164-165","first-page":"71","article-title":"Physical assessment and observational gait analysis","author":"Trost","year":"2004"},{"issue":"February 2023","key":"10.1016\/j.ejpn.2024.02.017_bib25","article-title":"The influence of ankle-foot orthoses on gait pathology in children with cerebral palsy: a retrospective study","volume":"100","author":"Everaert","year":"2023","journal-title":"Gait Posture [Internet]"},{"issue":"10","key":"10.1016\/j.ejpn.2024.02.017_bib26","article-title":"Are spasticity, weakness, selectivity, and passive range of motion related to gait deviations in children with spastic cerebral palsy? A statistical parametric mapping study","volume":"14","author":"Papageorgiou","year":"2019","journal-title":"PLoS One [Internet]"},{"issue":"9","key":"10.1016\/j.ejpn.2024.02.017_bib27","doi-asserted-by":"crossref","first-page":"1468","DOI":"10.1016\/j.jbiomech.2016.03.032","article-title":"The probability of false positives in zero-dimensional analyses of one-dimensional kinematic, force and EMG trajectories","volume":"49","author":"Pataky","year":"2016","journal-title":"J\u00a0Biomech [Internet]"},{"issue":"March","key":"10.1016\/j.ejpn.2024.02.017_bib28","article-title":"Reliability of four models for clinical gait analysis","volume":"54","author":"Kainz","year":"2017","journal-title":"Gait Posture [Internet]"},{"issue":"4","key":"10.1016\/j.ejpn.2024.02.017_bib29","doi-asserted-by":"crossref","first-page":"612","DOI":"10.1016\/j.gaitpost.2011.12.008","article-title":"The minimal clinically important difference for the Gait Profile Score","volume":"35","author":"Baker","year":"2012","journal-title":"Gait Posture"},{"issue":"12","key":"10.1016\/j.ejpn.2024.02.017_bib30","doi-asserted-by":"crossref","first-page":"918","DOI":"10.1111\/j.1469-8749.2008.03150.x","article-title":"Outcome tools used for ambulatory children with cerebral palsy: responsiveness and minimum clinically important differences","volume":"50","author":"Oeffinger","year":"2008","journal-title":"Dev. Med. Child Neurol."},{"key":"10.1016\/j.ejpn.2024.02.017_bib31","series-title":"Statistical Power and Analysis for the Behavioral Sciences","author":"Cohen","year":"1988"},{"issue":"7","key":"10.1016\/j.ejpn.2024.02.017_bib32","doi-asserted-by":"crossref","first-page":"2327","DOI":"10.1007\/s11999-013-2897-7","article-title":"The influence of botulinum toxin a injections into the calf muscles on genu recurvatum in children with cerebral palsy pediatrics","volume":"471","author":"Klotz","year":"2013","journal-title":"Clin. Orthop. Relat. Res."},{"key":"10.1016\/j.ejpn.2024.02.017_bib33","series-title":"The Gait Pattern Classification System for Children with Spastic Cerebral Palsy (GaP-CP) - Part 2. Pattern-specific Clinical Phenotypes","author":"Papageorgiou","year":"2022"},{"issue":"4","key":"10.1016\/j.ejpn.2024.02.017_bib34","doi-asserted-by":"crossref","first-page":"390","DOI":"10.1302\/1863-2548.12.180044","article-title":"Onabotulinum toxin-A (Botox) for spastic equinus in cerebral palsy: a prospective kinematic study","volume":"12","author":"Hastings-Ison","year":"2018","journal-title":"J\u00a0Child Orthop [Internet]"},{"issue":"3","key":"10.1016\/j.ejpn.2024.02.017_bib35","doi-asserted-by":"crossref","first-page":"268","DOI":"10.3109\/01942638.2016.1150384","article-title":"Effects of botulinum toxin-A and goal-directed physiotherapy in children with cerebral palsy GMFCS levels I & II","volume":"37","author":"L\u00f6wing","year":"2017","journal-title":"Phys. Occup. Ther. Pediatr."},{"issue":"April","key":"10.1016\/j.ejpn.2024.02.017_bib36","first-page":"1","article-title":"Joint and muscle assessments of the separate effects of botulinum NeuroToxin-A and lower-leg casting in children with cerebral palsy","volume":"11","author":"Peeters","year":"2020","journal-title":"Front. Neurol."},{"issue":"5","key":"10.1016\/j.ejpn.2024.02.017_bib37","doi-asserted-by":"crossref","first-page":"1629","DOI":"10.3390\/toxins7051629","article-title":"Best clinical practice in botulinum toxin treatment for children with cerebral palsy","volume":"7","author":"Strobl","year":"2015","journal-title":"Toxins"},{"key":"10.1016\/j.ejpn.2024.02.017_bib38","doi-asserted-by":"crossref","first-page":"209","DOI":"10.1016\/j.gaitpost.2019.01.038","article-title":"Systematic review on gait classifications in children with cerebral palsy: an update","volume":"69","author":"Papageorgiou","year":"2019","journal-title":"Gait Posture [Internet]"},{"key":"10.1016\/j.ejpn.2024.02.017_bib39","series-title":"International Classification of Functioning, Disability and Health (ICF)","author":"World Health Organization","year":"2001"}],"container-title":["European Journal of Paediatric Neurology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1090379824000242?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1090379824000242?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2024,4,29]],"date-time":"2024-04-29T10:48:45Z","timestamp":1714387725000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S1090379824000242"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2024,3]]},"references-count":39,"alternative-id":["S1090379824000242"],"URL":"https:\/\/doi.org\/10.1016\/j.ejpn.2024.02.017","relation":{},"ISSN":["1090-3798"],"issn-type":[{"value":"1090-3798","type":"print"}],"subject":[],"published":{"date-parts":[[2024,3]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Botulinum neurotoxin type A responders among children with spastic cerebral palsy: Pattern-specific effects","name":"articletitle","label":"Article Title"},{"value":"European Journal of Paediatric Neurology","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.ejpn.2024.02.017","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2024 European Paediatric Neurology Society. Published by Elsevier Ltd. All rights reserved.","name":"copyright","label":"Copyright"}]}}